Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

Interventional Oncology

Products

Solutions

 

 

Chemoembolization of Hepatocellular Carcinoma with Drug-Eluting Polyethylene Glycol Embolic Agents: Single-Center Retrospective Analysis in 302 Patientshttps://www.terumo-europe.com/en-emea/clinicaldata/chemoembolization-of-hepatocellular-carcinoma-with-drug-eluting-polyethylene-glycol-embolic-agents-single-center-retrospectiveChemoembolization of Hepatocellular Carcinoma with Drug-Eluting Polyethylene Glycol Embolic Agents: Single-Center Retrospective Analysis in 302 Patients​Filipe Veloso Gomes, MBChB, BSc, João A. Oliveira, MD, Mariana Tomé Correia, MD, Nuno Vasco Costa, MD, João Abrantes, MD, Daniel Torres, MD, Pedro Pereira, MD, Ana Isabel Ferreira, MD, José Hugo Luz, MD, Erik Spaepen, MSc, Tiago Bilhim, MD, PhD, and Élia Coimbra, MDHayabusaArticlePage
Safety and efficacy of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinomahttps://www.terumo-europe.com/en-emea/clinical-program/Pages/Safety-and-efficacy-of-balloon‐occluded-transcatheter-arterial-chemoembolization-using-miriplatin-for-hepatocellular-carcin.aspxSafety and efficacy of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma<p>​Hirotaka Arai et al Gunma University Graduate School of Medicine, Maebashi, Japan</p>HayabusaArticlePage
Safety and efficacy of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinomahttps://www.terumo-europe.com/en-emea/clinicaldata/safety-and-efficacy-of-balloon‐occluded-transcatheter-arterial-chemoembolization-using-miriplatin-for-hepatocellular-carcinomaSafety and efficacy of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma<p>​Hirotaka Arai et al Gunma University Graduate School of Medicine, Maebashi, Japan</p>HayabusaArticlePage

 

 

 

 

​1 Compared to similar products on the market

  • Initial Clinical Experience with Biopolymercoated Detachable Coils (HydroCoil) in Peripheral Embolization Procedures, Ashwin P et al. - July 2008 JVIR
  • Long-term Outcomes of Coil Packing for Visceral Aneurysms: Correlation between Packing Density and Incidence of Coil Compaction or Recanalization, Taku Yasumoto et al. J Vasc Interv Radiol 2013; 24:1798–1807
  • Data on file. LifePearl Drug Eluting Microspheres for Embolization - Product Development and Testing. Ref LPMCV-004 
  • Data on file. LifePearl Suspensions Characteristics and Diameter Comparison. Ref LPMCV-010 
  • Data on file. Comparative Diameter Distribution of LifePearl and other Microspheres. Ref LPMCV-012

 

 

New data demonstrate clinical experience with LifePearl microspheres in over 300 hepatocellular carcinoma patientshttps://www.terumo-europe.com/en-emea/news/new-data-demonstrate-clinical-experience-with-lifepearl-microspheres-in-over-300-hepatocellular-carcinoma-patientsNew data demonstrate clinical experience with LifePearl microspheres in over 300 hepatocellular carcinoma patientsLeuven, Belgium18/06/2018 22:00:00
Terumo and Quirem welcome the positive reimbursement decision for QuiremSpheres® in the Netherlandshttps://www.terumo-europe.com/en-emea/news/terumo-and-quirem-welcome-the-positive-reimbursement-decision-for-quiremspheres®-in-the-netherlandsTerumo and Quirem welcome the positive reimbursement decision for QuiremSpheres® in the NetherlandsLeuven, Belgium11/04/2018 22:00:00
Approval of LifePearl® Microspheres as a Class III device in Europehttps://www.terumo-europe.com/en-emea/news/approval-of-lifepearl®-microspheres-as-a-class-iii-device-in-europeApproval of LifePearl® Microspheres as a Class III device in EuropeLeuven, Belgium18/01/2018 23:00:00

 

 

Terumo at EANM 2018https://www.terumo-europe.com/en-emea/Events/Terumo at EANM 2018.aspxTerumo at EANM 2018Germany12/10/2018 22:00:0017/10/2018 16:00:00Düsseldorfhttp://publishing-prd.terumo-europe.com/en-emea/events/terumo-at-eanm-2018, https://www.terumo-europe.com/en-emea/events/terumo-at-eanm-2018
ESMO 2018https://www.terumo-europe.com/en-emea/Events/ESMO 2018.aspxESMO 2018Germany18/10/2018 22:00:0023/10/2018 15:18:00Munichhttp://www.esmo.org/Conferences/ESMO-2018-Congress, http://www.esmo.org/Conferences/ESMO-2018-Congress